Literature DB >> 10887089

A Caenorhabditis elegans type I TGF beta receptor can function in the absence of type II kinase to promote larval development.

C V Gunther1, L L Georgi, D L Riddle.   

Abstract

The daf-4 gene encodes a type II bone morphogenetic protein receptor in Caenorhabditis elegans that regulates dauer larva formation, body size and male tail patterning. The putative type I receptor partner for DAF-4 in regulating dauer larva formation is DAF-1. Genetic tests of the mechanism of activation of these receptors show that DAF-1 can signal in the absence of DAF-4 kinase activity. A daf-1 mutation enhances dauer formation in a daf-4 null background, whereas overexpression of daf-1 partially rescues a daf-4 mutant. DAF-1 alone cannot fully compensate for the loss of DAF-4 activity, indicating that nondauer development normally results from the activities of both receptors. DAF-1 signaling in the absence of a type II kinase is unique in the type I receptor family. The activity may be an evolutionary remnant, owing to daf-1's origin near the type I/type II divergence, or it may be an innovation that evolved in nematodes. daf-1 and daf-4 promoters both mediated expression of green fluorescent protein in the nervous system, indicating that a DAF-1/DAF-4 receptor complex may activate a neuronal signaling pathway. Signaling from a strong DAF-1/DAF-4 receptor complex or a weaker DAF-1 receptor alone may provide larvae with more precise control of the dauer/nondauer decision in a range of environmental conditions.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10887089     DOI: 10.1242/dev.127.15.3337

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  37 in total

1.  A DAF-1-binding protein BRA-1 is a negative regulator of DAF-7 TGF-beta signaling.

Authors:  K Morita; M Shimizu; H Shibuya; N Ueno
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-15       Impact factor: 11.205

2.  Autophagy genes unc-51 and bec-1 are required for normal cell size in Caenorhabditis elegans.

Authors:  István Aladzsity; Márton L Tóth; Tímea Sigmond; Emese Szabó; Bertalan Bicsák; János Barna; Agnes Regos; László Orosz; Attila L Kovács; Tibor Vellai
Journal:  Genetics       Date:  2007-09       Impact factor: 4.562

Review 3.  TGF-β signaling in C. elegans.

Authors:  Tina L Gumienny; Cathy Savage-Dunn
Journal:  WormBook       Date:  2013-07-10

4.  A Caenorhabditis elegans TGF-beta, DBL-1, controls the expression of LON-1, a PR-related protein, that regulates polyploidization and body length.

Authors:  Kiyokazu Morita; Anthony J Flemming; Yukiko Sugihara; Makoto Mochii; Yo Suzuki; Satoru Yoshida; William B Wood; Yuji Kohara; Armand M Leroi; Naoto Ueno
Journal:  EMBO J       Date:  2002-03-01       Impact factor: 11.598

5.  Label-free quantitative analysis of lipid metabolism in living Caenorhabditis elegans.

Authors:  Thuc T Le; Holli M Duren; Mikhail N Slipchenko; Chang-Deng Hu; Ji-Xin Cheng
Journal:  J Lipid Res       Date:  2009-09-23       Impact factor: 5.922

6.  Antagonistic Smad transcription factors control the dauer/non-dauer switch in C. elegans.

Authors:  Donha Park; Annette Estevez; Donald L Riddle
Journal:  Development       Date:  2010-02       Impact factor: 6.868

Review 7.  C. elegans dauer formation and the molecular basis of plasticity.

Authors:  Nicole Fielenbach; Adam Antebi
Journal:  Genes Dev       Date:  2008-08-15       Impact factor: 11.361

8.  Neural and molecular dissection of a C. elegans sensory circuit that regulates fat and feeding.

Authors:  Elisabeth R Greer; Carissa L Pérez; Marc R Van Gilst; Brian H Lee; Kaveh Ashrafi
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

9.  The T-box gene tbx-2, the homeobox gene egl-5 and the asymmetric cell division gene ham-1 specify neural fate in the HSN/PHB lineage.

Authors:  Aakanksha Singhvi; C Andrew Frank; Gian Garriga
Journal:  Genetics       Date:  2008-05-27       Impact factor: 4.562

10.  ASI regulates satiety quiescence in C. elegans.

Authors:  Thomas Gallagher; Jeongho Kim; Marieke Oldenbroek; Rex Kerr; Young-Jai You
Journal:  J Neurosci       Date:  2013-06-05       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.